Actively Recruiting
Laparoscopic or Abdominal Radical Hysterectomy for Cervical Cancer(Stage IA1 With LVSI, IA2)
Led by Hua Jiang · Updated on 2021-11-10
690
Participants Needed
1
Research Sites
244 weeks
Total Duration
On this page
Sponsors
H
Hua Jiang
Lead Sponsor
C
Children's Hospital of Fudan University
Collaborating Sponsor
AI-Summary
What this Trial Is About
The purpose of this study is to confirm whether there is a difference between laparoscopic radical hysterectomy (LRH) and abdominal radical hysterectomy (ARH) in patient survival for Cervical Cancer (Stage IA1 with LVSI, IA2)
CONDITIONS
Official Title
Laparoscopic or Abdominal Radical Hysterectomy for Cervical Cancer(Stage IA1 With LVSI, IA2)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Clinical diagnosis of squamous carcinoma, adenocarcinoma, or squamous adenocarcinoma of the cervix (Stage IA1 with lymphovascular invasion or Stage IA2)
- Age between 21 and 70 years
- Planned surgery type B or C according to Querleu-Morrow surgical staging
- Normal liver and kidney function and blood counts: Hemoglobin > 60 g/L, Platelets > 70 x 10^9/L, Leukocytes > 3 x 10^9/L, Creatinine < 50 mg/dL, Transaminases no more than 3 times the normal limit
- No history of other cancers
- Not pregnant
- Karnofsky score of 60 or higher
- Willing to join the study, sign consent, and comply with follow-up
- No psychiatric or serious immune system disorders such as lupus, myasthenia gravis, or HIV infection
- Cervical lesion size measured by PET-CT, CT, or MRI as specified
You will not qualify if you...
- Unable to undergo surgery due to medical contraindications
- Previous pelvic or abdominal radiotherapy or neoadjuvant chemotherapy for cervical cancer
- Recurrent cervical cancer
- Imaging (CT, MRI, PET-CT) showing suspected pelvic lymph node metastasis larger than 2 cm
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
The Obstetrics and Gynecology Hospital of Fudan University
Shanghai, China, 20000
Actively Recruiting
Research Team
H
Hua Jiang, PHD
CONTACT
X
Xin Wu, PHD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here